%PDF-1.4
%
37 0 obj
<>
endobj
34 0 obj
<>
endobj
94 0 obj
<>stream
Acrobat Distiller 4.05 for Macintosh
2004-12-02T18:12:36Z
2024-03-28T11:56:04-07:00
QuarkXPressª: AdobePS 8.6 (219)
2024-03-28T11:56:04-07:00
application/pdf
Heather
2001-339.jan
uuid:956d4d9f-1dd1-11b2-0a00-c90827bd7200
uuid:956d4da2-1dd1-11b2-0a00-880000000000
endstream
endobj
23 0 obj
<>
endobj
24 0 obj
<>
endobj
38 0 obj
<>/ExtGState<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Type/Page>>
endobj
1 0 obj
<>/ExtGState<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Type/Page>>
endobj
4 0 obj
<>/ExtGState<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Type/Page>>
endobj
7 0 obj
<>/ExtGState<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Type/Page>>
endobj
10 0 obj
<>/ExtGState<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Type/Page>>
endobj
13 0 obj
<>/ExtGState<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Type/Page>>
endobj
116 0 obj
[120 0 R]
endobj
117 0 obj
<>stream
1 g
/GS0 gs
0 792 m
0 792 l
f
q
-1 793 614 -794 re
W n
q
0 792.06 612 -792 re
W n
BT
/CS0 cs 0 0 0 1 scn
/GS1 gs
/TT0 1 Tf
0.0249 Tw 8 0 0 8 57.2949 714.5293 Tm
[(1)36.9 (1.)-875 (Maeda S, Sawai )17.7 (T)74 (, Uzuki M, et al. Determination of interstitial)]TJ
-0.00011 Tc 2.1381 -1.25 Td
[(collagenase \(MMP-1\) in patients with rheumatoid arthritis. )54.8 (Ann)]TJ
0 Tc 0 -1.25 TD
(Rheum Dis 1995;54:970-5.)Tj
-2.175 -1.25 Td
[(12.)-875 (T)69.8 (etlow LC, )17.8 (W)79.8 (oolley DE. Comparative immunolocalization studies)]TJ
2.175 -1.25 Td
(of collagenase 1 and collagenase 3 production in the rheumatoid)Tj
T*
(lesion, and by human chondrocytes and synoviocytes in vitro. Br J)Tj
T*
(Rheumatol 1998;37:64-70.)Tj
-2.175 -1.25 Td
[(13.)-875 (Rutter JL, Mitchell )17.8 (TI, Buttice G, et al. )54.9 (A)-219.8 (single nucleotide)]TJ
2.175 -1.25 Td
(polymorphism in the matrix metalloproteinase-1 promoter creates)Tj
T*
(an Ets binding site and augments transcription. Cancer Res)Tj
0 Tw T*
(1998;58:5321-5.)Tj
0.02499 Tw -2.175 -1.25 Td
[(14.)-875 (Kanamori )36.9 (Y)129.2 (,)0.1 ( Matsushima M, Minaguchi )17.8 (T)74 (, et al. Correlation)]TJ
2.175 -1.25 Td
(between expression of the matrix metalloproteinase-1 gene in)Tj
T*
(ovarian cancers and an insertion/deletion polymorphism in its)Tj
T*
(promoter region. Cancer Res 1999;59:4225-7.)Tj
-0.00011 Tc -2.175 -1.25 Td
[(15.)-875.1 (Y)100 (e)-0.1 ( S, Dhillon S, )17.7 (T)34.8 (urner SJ, et al. Invasiveness of cutaneous)]TJ
0 Tc 2.175 -1.25 Td
(malignant melanoma is influenced by matrix metalloproteinase 1)Tj
T*
(gene polymorphism. Cancer Res 2001;61:1296-8.)Tj
-2.175 -1.25 Td
[(16.)-875 (Noll )17.8 (WW)91.8 (, Belloni DR, Rutter JL, et al. Loss of heterozygosity on)]TJ
2.175 -1.25 Td
[(chromosome 1)36.9 (1q22-23 in melanoma is associated with retention of)]TJ
T*
(the insertion polymorphism in the matrix metalloproteinase-1)Tj
T*
[(promoter)54.9 (. )54.9 (Am J Pathol 2001;158:691-7.)]TJ
-0.00011 Tc -2.175 -1.25 Td
[(17.)-875.1 (Arnett FC, Edworthy SM, Bloch DA, et al. )17.7 (The )54.8 (American)]TJ
2.175 -1.25 Td
[(Rheumatism )54.8 (Association 1987 revised criteria for the classification)]TJ
0 Tc T*
[(of rheumatoid arthritis. )54.8 (Arthritis Rheum 1988;31:315-24.)]TJ
-2.175 -1.25 Td
[(18.)-875 (Guillemin F)79.8 (, Braincon S, Pourel J. [Measurement of the functional)]TJ
2.175 -1.25 Td
(capacity in rheumatoid polyarthritis: a French adaptation of the)Tj
-0.00011 Tc 33 32.5 Td
[(Health )54.8 (Assessment Questionnaire \(HAQ\)]. Rev Rhum Mal)]TJ
0 Tc T*
(Osteoartic 1991;58:459-65. )Tj
-2.175 -1.25 Td
[(19.)-875 (van der Heijde DM, van \221t Hof MA, van Riel PL, et al. Judging)]TJ
2.175 -1.25 Td
(disease activity in clinical practice in rheumatoid arthritis: first ste\
p)Tj
T*
[(in the development of a disease activity score. )54.8 (Ann Rheum Dis)]TJ
0 Tw T*
(1990;49:916-20.)Tj
0.02499 Tw -2.175 -1.25 Td
[(20.)-875 (van der Heijde D. How to read radiographs according to the)]TJ
2.175 -1.25 Td
(Sharp/van der Heijde method. J Rheumatol 1999;26:743-5.)Tj
-0.00011 Tc -2.175 -1.25 Td
[(21.)-875.1 (Bignon JD, Fernandez-V)59.7 (inas F)79.7 (. HLA)-220.2 (et M\351decine. In: Charron D,)]TJ
0 Tc 2.175 -1.25 Td
(Fauchet R, editors. XIIth International Histocompatibility)Tj
T*
[(W)79.8 (orkshop technical handbook. Paris: EDK Publishers; 1995.)]TJ
-2.175 -1.25 Td
[(22.)-875 (Cuzick J. )54.9 (A)-202 (W)39.8 (ilcoxon-type test for trend. Stat Med 1985;4:87-90.)]TJ
-0.00011 Tc T*
[(23.)-875.1 (Erdfelder E, Faul F)79.7 (,)-0.1 ( Buchner )54.8 (A. Gpower: a general power analysis)]TJ
0 Tc 2.175 -1.25 Td
[(program. Behav Res Methods Instrum Comput 1996;28:1-1)36.8 (1.)]TJ
-2.175 -1.25 Td
[(24.)-875 (Gough )54.9 (A, Faint J, Salmon M, et al. Genetic typing of patients with)]TJ
2.175 -1.25 Td
(inflammatory arthritis at presentation can be used to predict)Tj
T*
[(outcome. )54.9 (Arthritis Rheum 1994;37:1)36.8 (166-70.)]TJ
-0.00011 Tc -2.175 -1.25 Td
[(25.)-875.1 (Reveille JD, )54.8 (Alarcon GS, Fowler SE, et al. HLA-DRB1 genes and)]TJ
0 Tc 2.175 -1.25 Td
[(disease severity in rheumatoid arthritis. )17.7 (The MIRA)-202.3 (T)34.9 (rial Group.)]TJ
T*
[(Minocycline in rheumatoid arthritis. )54.8 (Arthritis Rheum)]TJ
0 Tw T*
(1996;39:1802-7.)Tj
-0.00011 Tc 0.02499 Tw -2.175 -1.25 Td
[(26.)-875.1 (Nepom GT)73.9 (, Gersuk )17.7 (V)129.1 (, Nepom BS. Prognostic implications of HLA)]TJ
0 Tc 2.175 -1.25 Td
(genotyping in the early assessment of patients with rheumatoid)Tj
T*
(arthritis. J Rheumatol 1996;23 Suppl 44:5-9.)Tj
ET
/CS0 CS 0 0 0 1 SCN
54 54 m
558 54 l
S
BT
/TT1 1 Tf
8 0 0 8 424.3613 35.9844 Tm
(The Journal of Rheumatology 2002; 29:1)Tj
0 Tw -46.2952 -0.0313 Td
(20)Tj
ET
0 0 0 0 scn
/GS0 gs
103.5 59.08 407.5 -10.83 re
f*
0.5 w
103.5 59.08 407.5 -10.83 re
S
Q
Q
q
0 0 612 792 re
W n
BT
0 g
/GS2 gs
/T1_0 8 Tf
120.092 51 Td
(Personal non-commercial use only. The Journal of Rheumatology Copyright\
\251 2002. All rights reserved.)Tj
ET
Q
BT
0 g
/GS2 gs
/T1_1 1 Tf
10 0 0 10 540 17 Tm
( )Tj
0 0.48627 0.77255 rg
/GS2 gs
-7.22298 0 Td
(www.jrheum.org)Tj
0 g
/GS2 gs
-16.72996 0 Td
(Downloaded on March 28, 2024 from )Tj
ET
endstream
endobj
81 0 obj
<>
endobj
99 0 obj
<>
endobj
46 0 obj
<>
endobj
42 0 obj
<>
endobj
40 0 obj
<>
endobj
71 0 obj
<>stream
HV pUBBN& 9f j8
]\\@AR(`p)Y
Lדpi@ hj(RVz_.0cc
m6PIJªJԎԝ%/@1Kg/,PF/+mxҧwQ
cE~IKYyNo Ԉs
p>|Ty`AEd|ٴ_
~(O<}*̯nQҳb^q?dB:'iDIZ>+H3IVHˆ;TcKI[q `1o]\V#F.AbV60Ee8FTxqiFۿr}
bp318$kp\|*:FzQeXko
C̷0uy9*q -q]"RtD#x!;M![`FG܋ ΈRr}WvF[
@ܓ1
H]D[d|N9^UUeZd'd/"Qk:[Oda?3Є/4bq^F8iȡV'˚76
<3
qsbwXʱ`> ۉr/197 p(DGHHnVm0'Ɖ*DTbXK{+9\X_<+g%RIQ\q:\Тi"ZVOPUrZVUe-6[uJF-a#(I(D f7X
&f1vO,av's~=<@H@s"s3 "_d1UL%LEqZ"v]⠸&nl&d;LvfEr|[+76gi=()h%UUF)c2WYlU)ە(Ǖ&@yfԱ"z"mj9힣t7+،|Ӟ|! FE\gʾ|wON!>?r85b'xIm$RH װ.xZBCyRgV:1LV?7WH14%-ywfFs]MKbƥw1)1!>.CgŴnպUdӡ~Lj1b '~S(iS-=,R1Н{
l1:1i59Fn6ףk5-̴!rC&^3,0^﮷rg]ܠvd8^3FNXzEf87U4ŰBc c6=t3Za'Uu1ψ*2}(ha9fW-o4ejn8Ҭm.ȗtƔ|X
׆ޜD%i5ʂ3yRIIz?j^=8g:]DƝYd%wq%6Oo;t&l ƋuLU¾4S Xf00]S-5Ѓ?m4n<- H1?^~t`632t)fmpX˝Yev4*bt#K<1P?uw얭`:z1nx2
L5jbmMC#wӸ_X3"ѧmL\{oYSuqXok$I%